EUVIMEDEUVIMED entdecken
Crossref

The Impact of Severe COVID-19 Infection on Renal and Liver Markers (Urea, Creatinine, GOT, GPT) in Diabetic Patients

Marwah S. Yones, Estabraq A. Alwasiti, Abdul Hameed A. Al-Qaseer, Anees K. Nile

Iraqi Journal of Medical Sciences · 14.12.2023 · 21 (2)

DOI: 10.22578/ijms.21.2.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iraqi Journal of Medical Sciences, online erschienen am 14.12.2023. Verfasst von Marwah S. Yones und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronavirus disease 2019 (COVID-19), an epidemic illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affecting the lower respiratory tract. It may impact renal and hepatic function by causing a cytokine storm and inflammation. Although numerous studies on the effects of COVID-19 on people with diabetes Mellitus (DM) have been conducted across the globe, their conclusions have varied due to differences in study populations' demographics, racial and ethnic composition, and geographic locations.

Objective

To comprehend the effects of a severe COVID-19 infection on renal and hepatic function in patients with diabetes mellitus.

Methods

This study was carried out at the Chemistry and Biochemistry Department of Al-Nahrain University in Baghdad, Iraq. A total of 100 participants with a severe case of COVID-19 were included in the study between February and April 2022. There was a total of 100 hospital admissions due to COVID-19; 50 of these patients had diabetes, while the other 50 did not. In both groups, serum urea, creatinine, glutamic-oxaloacetic ?transaminase (GOT) and glutamic-pyruvic ?transaminase (GPT) were mustered using ?appropriate methods.?

Results

The median concentration of the DM patients’ group had significantly lower concentration of urea, creatinine, GOT and GPT than non-DM patient’s group. While all these parameters were significantly higher in COVID-19 patients than in controls.

Conclusion

Diabetes (COVID-19 patients) exhibited lower levels of biochemical markers as compared to non-diabetic people. Patients with diabetes in COVID-19 take a range of drugs, including insulin injections. In severe circumstances, this medicine may disrupt biochemical markers in addition to the effects it has on renal and hepatic function from COVID-19. Keywords: COVID-19, diabetes Mellitus, urea, creatinine, GOT, and GPT. Citation: Yones MS, Alwasiti EA, Al-Qaseer AA, Nile AK. The Impact of severe COVID-19 infection on renal and liver markers (urea, creatinine, GOT, GPT) in diabetic patients. Iraqi JMS. 2023; 21(2): 237-244. doi: 10.22578/IJMS.21.2.11

Zitieren

APA

Yones, M. S., Alwasiti, E. A., Al-Qaseer, A. H. A., & Nile, A. K. (2023). The Impact of Severe COVID-19 Infection on Renal and Liver Markers (Urea, Creatinine, GOT, GPT) in Diabetic Patients. Iraqi Journal of Medical Sciences, 21(2). https://doi.org/10.22578/ijms.21.2.11

Vancouver

Yones MS, Alwasiti EA, Al-Qaseer AHA, Nile AK. The Impact of Severe COVID-19 Infection on Renal and Liver Markers (Urea, Creatinine, GOT, GPT) in Diabetic Patients. Iraqi Journal of Medical Sciences. 2023;21(2). doi:10.22578/ijms.21.2.11

BibTeX
@article{Yones2023,
  author = {Yones, Marwah S. and Alwasiti, Estabraq A. and Al-Qaseer, Abdul Hameed A. and Nile, Anees K.},
  title = {The Impact of Severe COVID-19 Infection on Renal and Liver Markers (Urea, Creatinine, GOT, GPT) in Diabetic Patients},
  journal = {Iraqi Journal of Medical Sciences},
  year = {2023},
  volume = {21},
  number = {2},
  doi = {10.22578/ijms.21.2.11}
}
Kostenlos starten →